Valentina Penalba1, Teresa L Deshields2, Dean Klinkenberg3. 1. Siteman Cancer, Barnes-Jewish Hospital, Washington University School of Medicine, 4921 Parkview Place, MS: 90-35-703, St. Louis, MO, 63110, USA. vpenalba@slu.edu. 2. School of Medicine, Washington University, Saint Louis, MO, USA. 3. Barnes-Jewish Hospital, Saint Louis, MO, USA.
Abstract
PURPOSE: Good communication between patients and healthcare professionals (HCPs) is an important contributor to patient well-being. Few studies have focused on the gaps in communication between patients and HCPs about symptoms. This study examined patients' perspectives on symptom distress, intention to discuss symptoms, and actual symptom discussion in medical oncology visits. METHODS: This was a cross-sectional descriptive study. Ninety-four patients provided demographic and clinical information and completed the Memorial Symptom Assessment Scale. Patients also answered questions about their plans for communication-and after the visit, their actual communication-with their medical team about their symptoms. RESULTS: Patients reported many symptoms by questionnaire; however, they did not plan to discuss-nor actually discussed-most of their symptoms with their HCPs. For all symptoms, fewer than 42% of patients with the symptom intended to discuss it (except for lack of energy and pain) and less than 50% actually discussed the symptom. For bothersome symptoms, less than 42% of those with the symptom intended to discuss it (except for lack of energy) and less than 40% actually discussed the symptom. Psychological symptoms were endorsed by 24-41% of patients, depending on the symptom; however, of those endorsing a symptom, most did not discuss it with an HCP. CONCLUSIONS: Results of this study support the perception of communication gaps between patients and HCPs about symptoms. Better understanding of these gaps is needed to ensure that patient-centered care is delivered and that patients' symptoms can be appropriately managed in oncology clinics.
PURPOSE: Good communication between patients and healthcare professionals (HCPs) is an important contributor to patient well-being. Few studies have focused on the gaps in communication between patients and HCPs about symptoms. This study examined patients' perspectives on symptom distress, intention to discuss symptoms, and actual symptom discussion in medical oncology visits. METHODS: This was a cross-sectional descriptive study. Ninety-four patients provided demographic and clinical information and completed the Memorial Symptom Assessment Scale. Patients also answered questions about their plans for communication-and after the visit, their actual communication-with their medical team about their symptoms. RESULTS:Patients reported many symptoms by questionnaire; however, they did not plan to discuss-nor actually discussed-most of their symptoms with their HCPs. For all symptoms, fewer than 42% of patients with the symptom intended to discuss it (except for lack of energy and pain) and less than 50% actually discussed the symptom. For bothersome symptoms, less than 42% of those with the symptom intended to discuss it (except for lack of energy) and less than 40% actually discussed the symptom. Psychological symptoms were endorsed by 24-41% of patients, depending on the symptom; however, of those endorsing a symptom, most did not discuss it with an HCP. CONCLUSIONS: Results of this study support the perception of communication gaps between patients and HCPs about symptoms. Better understanding of these gaps is needed to ensure that patient-centered care is delivered and that patients' symptoms can be appropriately managed in oncology clinics.
Entities:
Keywords:
Cancer patients; Medical communication; Memorial Symptom Assessment Survey; Symptom bother; Symptom reporting
Authors: Mille Guldager Christiansen; Helle Pappot; Charlotte Pedersen; Mary Jarden; Mansoor Raza Mirza; Karin Piil Journal: Support Care Cancer Date: 2021-11-18 Impact factor: 3.603
Authors: Maryum Zaidi; Daniel J Amante; Ekaterina Anderson; Mayuko Ito Fukunaga; Jamie M Faro; Christine Frisard; Rajani S Sadasivam; Stephenie C Lemon Journal: JMIR Cancer Date: 2022-08-09
Authors: Hester Stoorvogel; Jolanda van Haastregt; Maurice Theunissen; Janna Schoenmaekers; Ann Hoeben; Marieke van den Beuken-van Everdingen Journal: Eur J Cancer Care (Engl) Date: 2022-06-06 Impact factor: 2.328
Authors: Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark Journal: BMJ Open Date: 2021-07-21 Impact factor: 2.692